United States Bone Complication Treatment Market Report 2016

September 2016 | 122 pages | ID: U559E4BCFE6EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Bone Complication Treatment

Revenue, means the sales value of Bone Complication Treatment

This report studies sales (consumption) of Bone Complication Treatment in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer Inc. (USA)
• Abbott Laboratories (USA)
• Genentech Inc. (USA)
• GlaxoSmithKline Plc (UK)
• Immunomedics, Inc. (USA)
• Indevus Pharmaceuticals Inc. (USA)
• Novartis AG (Switzerland)
• OSI Pharmaceuticals, Inc. (USA)
• Paladin Labs Inc. (Canada)
• ALZA Corporation (USA)
• Amgen Inc. (USA)
• AstraZeneca PLC (UK)
• Medimmune, LLC (USA)
• Bristol-Myers Squibb Company (USA)
• Cell Genesys Inc. (USA)
• Dendreon Corporation (USA)
• EUSA Pharma, (USA) Inc. (USA)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Progenics Pharmaceuticals, Inc. (USA)
• Sanofi-Aventis SA (France)
• Spectrum Pharmaceuticals, Inc. (USA)
• Takeda Pharmaceutical Company Limited (Japan)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Bone Complication Treatment in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Bone Complication Treatment Market Report 2016

1 BONE COMPLICATION TREATMENT OVERVIEW

1.1 Product Overview and Scope of Bone Complication Treatment
1.2 Classification of Bone Complication Treatment
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Bone Complication Treatment
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Bone Complication Treatment (2011-2021)
  1.4.1 USA Bone Complication Treatment Sales and Growth Rate (2011-2021)
  1.4.2 USA Bone Complication Treatment Revenue and Growth Rate (2011-2021)

2 USA BONE COMPLICATION TREATMENT COMPETITION BY MANUFACTURERS

2.1 USA Bone Complication Treatment Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Bone Complication Treatment Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Bone Complication Treatment Average Price by Manufactures (2015 and 2016)
2.4 Bone Complication Treatment Market Competitive Situation and Trends
  2.4.1 Bone Complication Treatment Market Concentration Rate
  2.4.2 Bone Complication Treatment Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA BONE COMPLICATION TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Bone Complication Treatment Sales and Market Share by Type (2011-2016)
3.2 USA Bone Complication Treatment Revenue and Market Share by Type (2011-2016)
3.3 USA Bone Complication Treatment Price by Type (2011-2016)
3.4 USA Bone Complication Treatment Sales Growth Rate by Type (2011-2016)

4 USA BONE COMPLICATION TREATMENT SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Bone Complication Treatment Sales and Market Share by Application (2011-2016)
4.2 USA Bone Complication Treatment Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA BONE COMPLICATION TREATMENT MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer Inc. (USA)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Bone Complication Treatment Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Abbott Laboratories (USA)
  5.2.2 Bone Complication Treatment Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Abbott Laboratories (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Genentech Inc. (USA)
  5.3.2 Bone Complication Treatment Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Genentech Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 GlaxoSmithKline Plc (UK)
  5.4.2 Bone Complication Treatment Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 GlaxoSmithKline Plc (UK) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Immunomedics, Inc. (USA)
  5.5.2 Bone Complication Treatment Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Immunomedics, Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Indevus Pharmaceuticals Inc. (USA)
  5.6.2 Bone Complication Treatment Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Indevus Pharmaceuticals Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Novartis AG (Switzerland)
  5.7.2 Bone Complication Treatment Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Novartis AG (Switzerland) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 OSI Pharmaceuticals, Inc. (USA)
  5.8.2 Bone Complication Treatment Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 OSI Pharmaceuticals, Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Paladin Labs Inc. (Canada)
  5.9.2 Bone Complication Treatment Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Paladin Labs Inc. (Canada) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 ALZA Corporation (USA)
  5.10.2 Bone Complication Treatment Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 ALZA Corporation (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Amgen Inc. (USA)
5.12 AstraZeneca PLC (UK)
5.13 Medimmune, LLC (USA)
5.14 Bristol-Myers Squibb Company (USA)
5.15 Cell Genesys Inc. (USA)
5.16 Dendreon Corporation (USA)
5.17 EUSA Pharma, (USA) Inc. (USA)
5.18 F. Hoffmann-La Roche Ltd. (Switzerland)
5.19 Progenics Pharmaceuticals, Inc. (USA)
5.20 Sanofi-Aventis SA (France)
5.21 Spectrum Pharmaceuticals, Inc. (USA)
5.22 Takeda Pharmaceutical Company Limited (Japan)

6 BONE COMPLICATION TREATMENT MANUFACTURING COST ANALYSIS

6.1 Bone Complication Treatment Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Bone Complication Treatment

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Bone Complication Treatment Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Bone Complication Treatment Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA BONE COMPLICATION TREATMENT MARKET FORECAST (2016-2021)

10.1 USA Bone Complication Treatment Sales, Revenue Forecast (2016-2021)
10.2 USA Bone Complication Treatment Sales Forecast by Type (2016-2021)
10.3 USA Bone Complication Treatment Sales Forecast by Application (2016-2021)
10.4 Bone Complication Treatment Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bone Complication Treatment
Table Classification of Bone Complication Treatment
Figure USA Sales Market Share of Bone Complication Treatment by Type in 2015
Table Application of Bone Complication Treatment
Figure USA Sales Market Share of Bone Complication Treatment by Application in 2015
Figure USA Bone Complication Treatment Sales and Growth Rate (2011-2021)
Figure USA Bone Complication Treatment Revenue and Growth Rate (2011-2021)
Table USA Bone Complication Treatment Sales of Key Manufacturers (2015 and 2016)
Table USA Bone Complication Treatment Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bone Complication Treatment Sales Share by Manufacturers
Figure 2016 Bone Complication Treatment Sales Share by Manufacturers
Table USA Bone Complication Treatment Revenue by Manufacturers (2015 and 2016)
Table USA Bone Complication Treatment Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Bone Complication Treatment Revenue Share by Manufacturers
Table 2016 USA Bone Complication Treatment Revenue Share by Manufacturers
Table USA Market Bone Complication Treatment Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Bone Complication Treatment Average Price of Key Manufacturers in 2015
Figure Bone Complication Treatment Market Share of Top 3 Manufacturers
Figure Bone Complication Treatment Market Share of Top 5 Manufacturers
Table USA Bone Complication Treatment Sales by Type (2011-2016)
Table USA Bone Complication Treatment Sales Share by Type (2011-2016)
Figure USA Bone Complication Treatment Sales Market Share by Type in 2015
Table USA Bone Complication Treatment Revenue and Market Share by Type (2011-2016)
Table USA Bone Complication Treatment Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Bone Complication Treatment by Type (2011-2016)
Table USA Bone Complication Treatment Price by Type (2011-2016)
Figure USA Bone Complication Treatment Sales Growth Rate by Type (2011-2016)
Table USA Bone Complication Treatment Sales by Application (2011-2016)
Table USA Bone Complication Treatment Sales Market Share by Application (2011-2016)
Figure USA Bone Complication Treatment Sales Market Share by Application in 2015
Table USA Bone Complication Treatment Sales Growth Rate by Application (2011-2016)
Figure USA Bone Complication Treatment Sales Growth Rate by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Inc. (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Bone Complication Treatment Sales Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunomedics, Inc. (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG (Switzerland) Bone Complication Treatment Sales Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Paladin Labs Inc. (Canada) Bone Complication Treatment Sales Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table ALZA Corporation (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table Amgen Inc. (USA) Basic Information List
Table Amgen Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Inc. (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca PLC (UK) Bone Complication Treatment Sales Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medimmune, LLC (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cell Genesys Inc. (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table Dendreon Corporation (USA) Basic Information List
Table Dendreon Corporation (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon Corporation (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Basic Information List
Table EUSA Pharma, (USA) Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Bone Complication Treatment Sales Market Share (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List
Table Progenics Pharmaceuticals, Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table Sanofi-Aventis SA (France) Basic Information List
Table Sanofi-Aventis SA (France) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis SA (France) Bone Complication Treatment Sales Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List
Table Spectrum Pharmaceuticals, Inc. (USA) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Bone Complication Treatment Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Bone Complication Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Bone Complication Treatment Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bone Complication Treatment
Figure Manufacturing Process Analysis of Bone Complication Treatment
Figure Bone Complication Treatment Industrial Chain Analysis
Table Raw Materials Sources of Bone Complication Treatment Major Manufacturers in 2015
Table Major Buyers of Bone Complication Treatment
Table Distributors/Traders List
Figure USA Bone Complication Treatment Production and Growth Rate Forecast (2016-2021)
Figure USA Bone Complication Treatment Revenue and Growth Rate Forecast (2016-2021)
Table USA Bone Complication Treatment Production Forecast by Type (2016-2021)
Table USA Bone Complication Treatment Consumption Forecast by Application (2016-2021)